Merck (MRK) Tops Q2 EPS by 12c; Raises Guidance
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $113.87 --0%
EPS Growth %: -0.9%
Financial Fact:
Less: Net Income Attributable to Noncontrolling Interests: 122.8M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -0.9%
Financial Fact:
Less: Net Income Attributable to Noncontrolling Interests: 122.8M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q2 EPS of ($2.06), $0.12 better than the analyst estimate of ($2.18). Revenue for the quarter came in at $15 billion versus the consensus estimate of $14.43 billion.
GUIDANCE:
Merck sees FY2023 EPS of $2.95-$3.05, versus the consensus of $2.60. Merck sees FY2023 revenue of $58.6-59.6 billion, versus the consensus of $53.2 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
- Seacoast Banking (SBCF) PT Raised to $34 at Piper Sandler
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
